Wilbanks Smith & Thomas Asset Management’s Elanco Animal Health ELAN Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$300K	Sell	18,450 -7,650	-29%	-$120K	0.01%	440
2023 Q4	$389K	Hold	26,100	–	–	0.01%	375
2023 Q3	$293K	Sell	26,100 -6,600	-20%	-$76.6K	0.01%	404
2023 Q2	$329K	Buy	32,700 +2,500	+8%	+$23.2K	0.01%	392
2023 Q1	$284K	Buy	30,200 +9,000	+42%	+$106K	0.01%	418
2022 Q4	$259K	Buy	+21,200	New	+$264K	0.01%	413

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's ELAN Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management reduced its Elanco Animal Health (ELAN) stake by 29% in Q1 2024, selling an estimated $120K and leaving 18,450 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #440.

Wilbanks Smith & Thomas Asset Management first reported a position in ELAN in Q4 2022 and has held it in 6 quarters since. The position peaked at $389K in Q4 2023. 376 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

Wilbanks Smith & Thomas Asset Management held 18,450 shares of Elanco Animal Health worth $300K as of Q1 2024.
Wilbanks Smith & Thomas Asset Management sold 7,650 Elanco Animal Health shares in Q1 2024, an estimated $120K.
Elanco Animal Health made up 0.01% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #440 holding.
Wilbanks Smith & Thomas Asset Management first reported a position in Elanco Animal Health in Q4 2022 and has held it in 6 quarters since.
Wilbanks Smith & Thomas Asset Management's Elanco Animal Health position peaked at $389K in Q4 2023.
376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.